Published in Thromb Res on January 01, 1991
Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res (2014) 0.81
The sequence of the human genome. Science (2001) 101.55
Cell-free formation of protease-resistant prion protein. Nature (1994) 6.07
Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature (1995) 4.22
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Importance of placement of intra-articular steroid injections. BMJ (1993) 2.77
Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A (1995) 2.58
Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J (2000) 2.42
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology (2005) 2.41
Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol (1997) 2.39
Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis (1993) 2.38
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol (2000) 2.15
Injury in rugby league: a four year prospective survey. Br J Sports Med (1996) 2.06
Laryngeal mask airway for caesarean section. Anaesthesia (1990) 2.05
Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis (1995) 2.02
Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods (1991) 2.01
Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J (2001) 1.95
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol (1994) 1.85
Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci U S A (1998) 1.80
Radiographic assessment of patellofemoral osteoarthritis. Ann Rheum Dis (1993) 1.79
Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci U S A (1997) 1.79
The chemistry of scrapie infection: implications of the 'ice 9' metaphor. Chem Biol (1995) 1.76
Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A (2000) 1.73
Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J (2001) 1.70
Are there two logistic regressions for retrospective studies? Biometrics (1978) 1.68
Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol (1999) 1.67
Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J (1999) 1.64
Behind the mask. Journey through an epidemic: some observations of contrasting public health responses to SARS. J Epidemiol Community Health (2003) 1.62
Health protection in the next millennium: from tactics to strategy? J Epidemiol Community Health (1999) 1.61
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology (2010) 1.57
Video-thoracoscopic pericardial window in the diagnosis and treatment of pericardial effusions. Am J Cardiol (1998) 1.55
Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci U S A (1997) 1.54
Perioperative immune modulation. Surgery (1993) 1.53
The double life of the prion protein. Curr Biol (1996) 1.48
A proposed minimal rheumatological screening history and examination. The joint answers back. J R Coll Physicians Lond (1991) 1.47
The confusion between disease and illness in clinical medicine. CMAJ (1986) 1.41
Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry (1996) 1.40
Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation. Hum Reprod (2002) 1.38
Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem (1998) 1.35
Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg (1996) 1.19
Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet. Ann Oncol (2010) 1.19
Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis. Ann Rheum Dis (1996) 1.16
A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem (1995) 1.15
Injury in summer rugby league football: the experiences of one club. Br J Sports Med (1998) 1.14
Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum (1982) 1.14
Enhanced surveillance of campylobacter infection in the North West of England 1997-1999. J Infect (2003) 1.09
Is osteoarthritis in women affected by hormonal changes or smoking? Br J Rheumatol (1993) 1.09
Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J Neurochem (1998) 1.09
Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect (2011) 1.09
Association of two loci on chromosome 2q with nodal osteoarthritis. Ann Rheum Dis (1996) 1.08
Value of syndromic surveillance in monitoring a focal waterborne outbreak due to an unusual Cryptosporidium genotype in Northamptonshire, United Kingdom, June - July 2008. Euro Surveill (2010) 1.08
Diagnostic implications of detection of proteinase K-resistant protein in spleen, lymph nodes, and brain of sheep. Am J Vet Res (1992) 1.07
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol (2011) 1.05
Prion protein and the molecular features of transmissible spongiform encephalopathy agents. Curr Top Microbiol Immunol (2004) 1.04
Prion protein interconversions and the transmissible spongiform encephalopathies. Structure (1999) 1.02
Analysis of linkage between scrapie incubation period and the prion protein gene in mice. J Gen Virol (1990) 1.02
The importance of the disulfide bond in prion protein conversion. Neuroreport (1998) 1.02
[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord (2001) 1.02
The changing epidemiology of cryptosporidiosis in North West England. Epidemiol Infect (2005) 1.01
Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol (2000) 1.01
Sperm DNA damage has a negative association with live-birth rates after IVF. Reprod Biomed Online (2012) 1.01
Foreign PrP expression and scrapie infection in tissue culture cell lines. Dev Biol Stand (1993) 1.01
Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem (2001) 1.01
Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells. J Virol (1991) 1.00
Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med (1984) 0.97
Vomiting calls to NHS Direct provide an early warning of norovirus outbreaks in hospitals. J Hosp Infect (2010) 0.96
Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J Neurochem (2001) 0.96
Growth of infective forms of Trypanosoma (T.) brucei on buffalo lung and Chinese hamster lung tissue culture cells. Acta Trop (1978) 0.95
Scrapie agent reflication without the prion protein? Curr Biol (1993) 0.94
Reversibility of scrapie-associated prion protein aggregation. J Biol Chem (2001) 0.94
Occupational hearing loss in New York dairy farmers. Am J Ind Med (1991) 0.94
In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices. J Biol Chem (1997) 0.94
Histopathologic features of composite ganglioneuroblastoma. Immunohistochemical distinction of the stromal component is related to prognosis. Cancer (1990) 0.93
Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol (1995) 0.93
Educational correlates of early and late sexual maturation in adolescence. J Pediatr (1982) 0.93
Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy. Parkinsonism Relat Disord (2007) 0.93
Provision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees? J Epidemiol Community Health (2002) 0.93
Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr (1988) 0.90
An operational model to investigate contact sports injuries. Med Sci Sports Exerc (2001) 0.90
Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units. J Public Health (Oxf) (2007) 0.89
How complete and accurate is meningococcal disease notification? Commun Dis Public Health (2004) 0.88
Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exercise. Am J Physiol Endocrinol Metab (2000) 0.88
Secondary structure of the pentraxin female protein in water determined by infrared spectroscopy: effects of calcium and phosphorylcholine. Biochemistry (1992) 0.88
Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology (2001) 0.87
Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infect Agents Dis (1995) 0.87
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford) (2007) 0.86
Lessons learned from SARS: the experience of the Health Protection Agency, England. Public Health (2005) 0.86
Novel therapeutic uses for porphyrins and phthalocyanines in the transmissible spongiform encephalopathies. Curr Opin Microbiol (1999) 0.86
Combined modality therapy for advanced head and neck cancer. Am J Surg (1980) 0.84
Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers. Am J Clin Pathol (1993) 0.84
Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function. J Cardiovasc Pharmacol (1995) 0.84
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology (2001) 0.84
Do dopamine agonists or levodopa modify Parkinson's disease progression? Eur J Neurol (2002) 0.84
Turf-toe: super league toe. Br J Sports Med (1997) 0.83
Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs. Arch Virol Suppl (2000) 0.83
The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease. AJNR Am J Neuroradiol (1991) 0.83